Editorial |
B and Cell Survival
From the Cardiovascular Division (R.T.L.), Department of Medicine, and the Vascular Research Division (T.C.), Department of Pathology, Brigham and Womens Hospital, Harvard Medical School, Boston, Mass.
Correspondence to Richard T. Lee, MD, Cardiovascular Division, Brigham and Womens Hospital, 75 Francis St, Boston, MA 02115. E-mail rlee@rics.bwh.harvard.edu
Key Words: apoptosis cell survival caspases cell cycle
| Introduction |
|---|
As a ubiquitous multifunctional signaling system, members of
the nuclear factor-
B (NF-
B) family play prominent roles in the
cell death/survival balance.1
NF-
B proteins are homodimers or heterodimers in the cytoplasm of
eukaryotic cells that share a 300 amino acid motif called the REL
homology domain.2 The REL
homology domain mediates dimer formation, nuclear localization, and
interaction with inhibitory proteins (I
B proteins) that keep NF-
B
proteins in the cytoplasm. Diverse cellular stimuli including
mechanical forces, oxidative stress, and cytokines lead to
phosphorylation of I
B proteins, allowing NF-
B dimers to enter the
nucleus and activate specific target genes.
Under many circumstances, activation of NF-
B complexes is
a powerful stimulus for cell survival
(Figure
).
For example, in B lymphocytes, the cell type in which NF-
B was
originally identified, engagement of cell surface IgM activates NF-
B
and inhibits apoptosis.3 In
addition, mice lacking RelA, one of the NF-
B family members, die at
embryonic development day 10 of massive hepatic
apoptosis.4 However, NF-
B
activation does
This article has been cited by other articles:
![]() |
B. Z. Carter, D. H. Mak, W. D. Schober, T. McQueen, D. Harris, Z. Estrov, R. L. Evans, and M. Andreeff Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells Blood, July 15, 2006; 108(2): 630 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xie and Z. A. Shaikh Cadmium-Induced Apoptosis in Rat Kidney Epithelial Cells Involves Decrease in Nuclear Factor-Kappa B Activity Toxicol. Sci., May 1, 2006; 91(1): 299 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. Carter, D. H. Mak, W. D. Schober, M. Cabreira-Hansen, M. Beran, T. McQueen, W. Chen, and M. Andreeff Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells Blood, February 15, 2006; 107(4): 1555 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Suetsugu, Y Iimuro, T Uehara, T Nishio, N Harada, M Yoshida, E Hatano, G Son, J Fujimoto, and Y Yamaoka Nuclear factor {kappa}B inactivation in the rat liver ameliorates short term total warm ischaemia/reperfusion injury Gut, June 1, 2005; 54(6): 835 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Freund, R. Schmidt-Ullrich, A. Baurand, S. Dunger, W. Schneider, P. Loser, A. El-Jamali, R. Dietz, C. Scheidereit, and M. W. Bergmann Requirement of Nuclear Factor-{kappa}B in Angiotensin II- and Isoproterenol-Induced Cardiac Hypertrophy In Vivo Circulation, May 10, 2005; 111(18): 2319 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, S. Chan, and B. K. Tsang Involvement of Inhibitory Nuclear Factor-{kappa}B (NF{kappa}B)-Independent NF{kappa}B Activation in the Gonadotropic Regulation of X-Linked Inhibitor of Apoptosis Expression during Ovarian Follicular Development in Vitro Endocrinology, July 1, 2002; 143(7): 2732 - 2740. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Razmara, S. M. Srinivasula, L. Wang, J.-L. Poyet, B. J. Geddes, P. S. DiStefano, J. Bertin, and E. S. Alnemri CARD-8 Protein, a New CARD Family Member That Regulates Caspase-1 Activation and Apoptosis J. Biol. Chem., April 12, 2002; 277(16): 13952 - 13958. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Santore, D. S. McClintock, V. Y. Lee, G. R. S. Budinger, and N. S. Chandel Anoxia-induced apoptosis occurs through a mitochondria-dependent pathway in lung epithelial cells Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L727 - L734. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. TEGEDER, J. PFEILSCHIFTER, and G. GEISSLINGER Cyclooxygenase-independent actions of cyclooxygenase inhibitors FASEB J, October 1, 2001; 15(12): 2057 - 2072. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |